- Display 15 Products per page
Published: December 17, 2015 | Price: $349.30 – $700.00
Point of Care (POC) Urinalysis Testing Market and Urinalysis Drugs of Abuse Testing Market Point of Care (POC) Urinalysis Testing Market and Urinalysis Drugs of Abuse Testing Market examines the urine strip segment of the global POC professional testing and self-testing markets and the urinalysis segment of the POC professional drugs of abuse testing market, including: Selected Dipstick Urinalysis Systems, 2014 Global POC Urine Strip Testing Market Analysis: 2012-2019 POC Urine Strip Self-Testing Market Analysis, 2014 and 2019 POC Urine...Published: December 14, 2015 | Price: $175.00 – $350.00
Hologic: Company Profile Hologic: Company Profile examines this leading developer, manufacturer, and supplier of premium diagnostic products, medical imaging systems and surgical products. The company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health. Hologic, Inc. is a leading developer, manufacturer and supplier of products dedicated to women’s health. Hologic provides products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, permanent contraception, osteoporosis assessment, preterm...Published: November 9, 2015 | Price: $250.00 – $500.00
QIAGEN: Company Profile QIAGEN, a leading global provider of sample and assay technologies, markets more than 500 products around the world, selling both consumable kits and automation systems to customers through four customer classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). QIAGEN: Company Profile examines the global healthcare company whose sample technologies isolate and process DNA, RNA and proteins from biological samples such as blood...Published: November 2, 2015 | Price: $250.00 – $500.00
Roche Diagnostics: Company Profile Roche Diagnostics: Company Profile examines the Swiss global research-based healthcare company. With product sales almost twice that of its nearest competition, Roche is the world's largest supplier of clinical diagnostics products. Roche is as well the global world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche is also the world's largest biotech company, with 14 biopharmaceuticals on the market. Further, Roche's personalized healthcare strategy aims at providing medicines...Published: November 1, 2015 | Price: $3,500.00 – $7,000.00
The World Market for Infectious Disease Diagnostic Tests World Market for Infectious Disease Tests provides detailed market estimates and forecasts for four major areas of infectious disease testing, including identification and antibiotic susceptibility testing, immunoassays, molecular testing and blood screening and subsegments within. POC and home testing markets for infectious disease are also provided. Sales and forecasts of infectious disease reagents are made through to 2019. Emerging products and markets are described; key players and strategies discussed and competitive trends...Published: October 26, 2015 | Price: $499.00 – $1,000.00
Mergers and Acquisitions in the IVD Market Mergers and Acquisitions in the IVD Market documents some 240 acquisitions that have taken place from 2012 to October 2015 in the extremely dynamic IVD industry. And this is likely only a small portion of what is really happening in the market; more deals are still to come. In vitro diagnostic (IVD) companies have been very busy with respect to acquisitions in an attempt to augment market share in an increasingly competitive market....Published: October 1, 2015 | Price: $1,995.00 – $3,995.00
Clinical Laboratory Services Market This report, Clinical Laboratory Services Market, provides an in-depth market overview, a total market analysis, analysis by laboratory type, and by routine and specialty testing and a review of the latest trends driving growth. Revenues and forecasts, segment breakouts and market share presented are for the U.S. market, but international clinical lab service markets are estimated and forecasted in this report. Laboratory services are a key component of the healthcare system and an important part of...Published: September 30, 2015 | Price: $1,999.00 – $3,995.00
Molecular tests are used in just about every facet of laboratory medicine: infectious diseases, inherited diseases, coagulation, transplant medicine, prenatal and postnatal screening and cancer. In The World Market for Molecular Diagnostics, 6th Edition, Kalorama IVD market analyst Shara Rosen, R.T., MBA provides authoritative and complete analysis of the molecular testing industry. In this report, exclusive market sizing and forecasts are provided for the following diagnostic segments: Cancer Markers & PGx Histology (In situ hybridization, HPV) Microbiology/Virology (HAI; HIV; Hepatitis;...Published: September 16, 2015 | Price: $1,995.00 – $3,995.00
Diabetes is a leading cause of death and disability in the worldwide. It increases the risk for heart disease, end-stage renal disease, blindness, amputation, and complications of pregnancy and is ranked as the sixth leading cause of death. Disease prevalence is driving sales of monitoring equipment. The glucose monitoring device and diabetes management market is focused on utilizing advancements recently introduced to provide easier-to-use products and more accurate glucose monitoring. This Kalorama information report, The Global Glucose Monitoring Market provides...Published: September 11, 2015 | Price: $1,995.00 – $3,995.00
The World Market for Cancer Diagnostics, 2014-2019, 6th Edition (Histology [ISH, IHC, HPV, Pap], Flow Cytometry, PSA, CEA, Liquid Biopsy, FOB and Other Rapid, Image Cytometry, Sequencing, Digital Pathology, Molecular Assays) Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis, therapy selection, therapy monitoring and early detection of cancer recurrence. The World Market for Cancer Diagnostics, 6th Edition., as well as relevant industry merger data provided by Kalorama Information,...Published: August 19, 2015 | Price: $1,995.00 – $3,990.00
The IVD Market in Vietnam presents current analysis of the Vietnamese IVD industry. Vietnam has demonstrated fast economic growth in recent years. Increases in foreign investment, wages, trade, industrialization and tourism have led to economic growth higher than that of many other economies in Asia. As a result, IVD companies searching for emerging market areas to pursue growth that is no longer possible in developed nations have targeted Vietnam. The report takes an in-depth look at the market, providing data...Published: June 11, 2015 | Price: $1,995.00 – $3,995.00
IVD in China Market Outlook 2014-2024 With a population of more than 1 billion, China is the world’s largest country and therefore also its single largest potential market for goods and services. In the past ten years, China has led all major world economies in the average rate of growth in real GDP, total health expenditures, and government health expenditures. As an in vitro diagnostics (IVD) market, China trails only the populous, developed markets of the United States, western European countries,...Published: June 2, 2015 | Price: $1,995.00 – $3,995.00
The World Market for Point of Care (POC) Diagnostics Visit our 'Point of Care Testing' curated page for complete industry coverage. Clinical diagnostic tests performed outside the central laboratory or decentralized testing are generally known as point of care (POC) diagnostic tests. The increasing introduction of transportable, portable, and handheld diagnostic instruments has resulted in the migration of point of care diagnostic testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and...Published: May 1, 2015 | Price: $1,995.00 – $3,995.00
The Market for Prenatal, Newborn and Carrier Genetic Testing The Market for Prenatal, Newborn and Carrier Genetic Testing discusses the technologies and tests used in chromosomal analysis and in the diagnosis of inherited disorders and the detection of carriers of inherited diseases. The growing global genetic testing laboratory services market is discussed, including: carrier testing prenatal testing newborn screening neonatal/pediatric testing testing for adult onset genetic disorders The growing number of genetic tests has been made possible by advances in...Published: April 17, 2015 | Price: $499.00 – $1,000.00
The Market for Clinical Chemistry Routine clinical chemistry comprises 30 to 40 tests of substrates, metabolites, electrolytes, blood gases, enzymes and lipids that can be organized into panels for specialty patient investigation and routine patient screening. Common specialty panels include those for renal clearance, liver function, and metabolic status. Clinical chemistries are performed on analyzers with varying levels of automation depending on the test volume run at a particular test site. The market for routine clinical chemistries can be segmented...